Individual Patient Compassionate Use of Nirogacestat
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
AgeNot listed
SponsorSpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
About this trial
This program is being offered on a patient by patient basis and will require company, Institutional Review Board/Independent Ethics Committee, and applicable competent authority approval.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient has a serious, debilitating or life-threatening medical condition that cannot be treated satisfactorily with an authorized medicinal product or other available standard treatment options, or all other treatment options have been exhausted.
Patient does not qualify to participate in an ongoing clinical trial.
Disqualifiers
None
Trial design
Treatments tested in this trial
Nirogacestat (Gamma Secretase Inhibitor)
DrugPatients will receive nirogacestat tablets to be taken orally.
Treatment groups
No treatment groups listed
Trial outcomes
This trial has no outcomes listed.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov